Cargando…
Breast Reconstruction Using Contour Fenestrated AlloDerm: Does Improvement in Design Translate to Improved Outcomes?
BACKGROUND: Acellular dermal matrices are used in implant-based breast reconstruction. The introduction of contour fenestrated AlloDerm (Life-Cell, Branchburg, N.J.) offers sterile processing, a crescent shape, and prefabricated fenestrations. However, any evidence comparing reconstructive outcomes...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596430/ https://www.ncbi.nlm.nih.gov/pubmed/26495218 http://dx.doi.org/10.1097/GOX.0000000000000482 |
_version_ | 1782393764326670336 |
---|---|
author | Frey, Jordan D. Alperovich, Michael Weichman, Katie E. Wilson, Stelios C. Hazen, Alexes Saadeh, Pierre B. Levine, Jamie P. Choi, Mihye Karp, Nolan S. |
author_facet | Frey, Jordan D. Alperovich, Michael Weichman, Katie E. Wilson, Stelios C. Hazen, Alexes Saadeh, Pierre B. Levine, Jamie P. Choi, Mihye Karp, Nolan S. |
author_sort | Frey, Jordan D. |
collection | PubMed |
description | BACKGROUND: Acellular dermal matrices are used in implant-based breast reconstruction. The introduction of contour fenestrated AlloDerm (Life-Cell, Branchburg, N.J.) offers sterile processing, a crescent shape, and prefabricated fenestrations. However, any evidence comparing reconstructive outcomes between this newer generation acellular dermal matrices and earlier versions is lacking. METHODS: Patients undergoing implant-based breast reconstruction from 2010 to 2014 were identified. Reconstructive outcomes were stratified by 4 types of implant coverage: aseptic AlloDerm, sterile “ready-to-use” AlloDerm, contour fenestrated AlloDerm, or total submuscular coverage. Outcomes were compared with significance set at P < 0.05. RESULTS: A total of 620 patients (1019 reconstructions) underwent immediate, implant-based breast reconstruction; patients with contour fenestrated AlloDerm were more likely to have nipple-sparing mastectomy (P = 0.0001, 0.0004, and 0.0001) and immediate permanent implant reconstructions (P = 0.0001). Those with contour fenestrated AlloDerm coverage had lower infection rates requiring oral (P = 0.0016) and intravenous antibiotics (P = 0.0012) compared with aseptic AlloDerm coverage. Compared with sterile “ready-to-use” AlloDerm coverage, those with contour fenestrated AlloDerm had similar infection outcomes but significantly more minor mastectomy flap necrosis (P = 0.0023). Compared with total submuscular coverage, those with contour fenestrated AlloDerm coverage had similar infection outcomes but significantly more explantations (P = 0.0001), major (P = 0.0130) and minor mastectomy flap necrosis (P = 0.0001). Significant independent risk factors for increased infection were also identified. CONCLUSIONS: Contour fenestrated AlloDerm reduces infections compared with aseptic AlloDerm, but infection rates are similar to those of sterile, ready-to-use AlloDerm and total submuscular coverage. |
format | Online Article Text |
id | pubmed-4596430 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-45964302015-10-22 Breast Reconstruction Using Contour Fenestrated AlloDerm: Does Improvement in Design Translate to Improved Outcomes? Frey, Jordan D. Alperovich, Michael Weichman, Katie E. Wilson, Stelios C. Hazen, Alexes Saadeh, Pierre B. Levine, Jamie P. Choi, Mihye Karp, Nolan S. Plast Reconstr Surg Glob Open Original Article BACKGROUND: Acellular dermal matrices are used in implant-based breast reconstruction. The introduction of contour fenestrated AlloDerm (Life-Cell, Branchburg, N.J.) offers sterile processing, a crescent shape, and prefabricated fenestrations. However, any evidence comparing reconstructive outcomes between this newer generation acellular dermal matrices and earlier versions is lacking. METHODS: Patients undergoing implant-based breast reconstruction from 2010 to 2014 were identified. Reconstructive outcomes were stratified by 4 types of implant coverage: aseptic AlloDerm, sterile “ready-to-use” AlloDerm, contour fenestrated AlloDerm, or total submuscular coverage. Outcomes were compared with significance set at P < 0.05. RESULTS: A total of 620 patients (1019 reconstructions) underwent immediate, implant-based breast reconstruction; patients with contour fenestrated AlloDerm were more likely to have nipple-sparing mastectomy (P = 0.0001, 0.0004, and 0.0001) and immediate permanent implant reconstructions (P = 0.0001). Those with contour fenestrated AlloDerm coverage had lower infection rates requiring oral (P = 0.0016) and intravenous antibiotics (P = 0.0012) compared with aseptic AlloDerm coverage. Compared with sterile “ready-to-use” AlloDerm coverage, those with contour fenestrated AlloDerm had similar infection outcomes but significantly more minor mastectomy flap necrosis (P = 0.0023). Compared with total submuscular coverage, those with contour fenestrated AlloDerm coverage had similar infection outcomes but significantly more explantations (P = 0.0001), major (P = 0.0130) and minor mastectomy flap necrosis (P = 0.0001). Significant independent risk factors for increased infection were also identified. CONCLUSIONS: Contour fenestrated AlloDerm reduces infections compared with aseptic AlloDerm, but infection rates are similar to those of sterile, ready-to-use AlloDerm and total submuscular coverage. Wolters Kluwer Health 2015-09-04 /pmc/articles/PMC4596430/ /pubmed/26495218 http://dx.doi.org/10.1097/GOX.0000000000000482 Text en Copyright © 2015 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. All rights reserved. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially. |
spellingShingle | Original Article Frey, Jordan D. Alperovich, Michael Weichman, Katie E. Wilson, Stelios C. Hazen, Alexes Saadeh, Pierre B. Levine, Jamie P. Choi, Mihye Karp, Nolan S. Breast Reconstruction Using Contour Fenestrated AlloDerm: Does Improvement in Design Translate to Improved Outcomes? |
title | Breast Reconstruction Using Contour Fenestrated AlloDerm: Does Improvement in Design Translate to Improved Outcomes? |
title_full | Breast Reconstruction Using Contour Fenestrated AlloDerm: Does Improvement in Design Translate to Improved Outcomes? |
title_fullStr | Breast Reconstruction Using Contour Fenestrated AlloDerm: Does Improvement in Design Translate to Improved Outcomes? |
title_full_unstemmed | Breast Reconstruction Using Contour Fenestrated AlloDerm: Does Improvement in Design Translate to Improved Outcomes? |
title_short | Breast Reconstruction Using Contour Fenestrated AlloDerm: Does Improvement in Design Translate to Improved Outcomes? |
title_sort | breast reconstruction using contour fenestrated alloderm: does improvement in design translate to improved outcomes? |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596430/ https://www.ncbi.nlm.nih.gov/pubmed/26495218 http://dx.doi.org/10.1097/GOX.0000000000000482 |
work_keys_str_mv | AT freyjordand breastreconstructionusingcontourfenestratedallodermdoesimprovementindesigntranslatetoimprovedoutcomes AT alperovichmichael breastreconstructionusingcontourfenestratedallodermdoesimprovementindesigntranslatetoimprovedoutcomes AT weichmankatiee breastreconstructionusingcontourfenestratedallodermdoesimprovementindesigntranslatetoimprovedoutcomes AT wilsonsteliosc breastreconstructionusingcontourfenestratedallodermdoesimprovementindesigntranslatetoimprovedoutcomes AT hazenalexes breastreconstructionusingcontourfenestratedallodermdoesimprovementindesigntranslatetoimprovedoutcomes AT saadehpierreb breastreconstructionusingcontourfenestratedallodermdoesimprovementindesigntranslatetoimprovedoutcomes AT levinejamiep breastreconstructionusingcontourfenestratedallodermdoesimprovementindesigntranslatetoimprovedoutcomes AT choimihye breastreconstructionusingcontourfenestratedallodermdoesimprovementindesigntranslatetoimprovedoutcomes AT karpnolans breastreconstructionusingcontourfenestratedallodermdoesimprovementindesigntranslatetoimprovedoutcomes |